top of page

Inspiring and empowering dreams, GeneLife’s Dream On campaign starts on DNA DAY!

Tokyo, April 25, 2023 – As part of DNA DAY 2023 and the year-long celebrations of its 20th anniversary, Genesis Healthcare Co. unleashes the dreams of its customers through the launch of its Dream On campaign.

GeneLife COVID-19 & Influenza PCR Test

With about 1.4 million tests performed and 20 years of continuous innovation in genetic science, Genesis Healthcare Co. is giving back to its customers, empowering them to achieve their dreams.

Through an on-line video promotion, 20 winners will have the opportunity to achieve their dreams by receiving an award of ¥1,000,000 (one million Japanese yen) to support their project.

GeneLife Dream On campaign information:

  • Application period: April 25th to May 16th, 2023.

  • Application procedure: - Participants are required to follow GeneLife’s official Instagram or Twitter channels. - Share the dream they wish to achieve by posting a video on GeneLife’s Instagram or Twitter channels with the hashtag #GeneLifeDreamOn.

  • Selection criteria: - After review by the campaign committee, winners will be directly notified. - GeneLife will announce the winners on its official GeneLife website and social media channels.

  • For detailed information and Terms & Conditions, please visit the GeneLife Dream On campaign site here.

For press and media inquiries, please contact:

For additional information, please visit:

About Genesis Healthcare Co.

Celebrating its 20th anniversary, Genesis Healthcare is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented AI driven prediction models, Genesis Healthcare provides advanced genetic testing services, from prevention to diagnostics.

GeneLife is a registered trademark of Genesis Healthcare Co.

DNA DAY is a registered trademark of Genesis Healthcare Co. in Japan.


bottom of page